| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Zic family member 3 | 0.587 | 0.423 | 0.92 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
WD repeat domain 35 | 0.525 | 0.692 | 1.0E-22 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
cripto, FRL-1, cryptic family 1 | 0.588 | 0.577 | 0.11 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
ring finger and WD repeat domain 3 | 0.569 | 0.731 | 3.5E-10 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
RAB23, member RAS oncogene family | 0.541 | 0.654 | 5.6E-03 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
cell adhesion associated, oncogene regulated | 0.601 | 0.731 | 2.1E-15 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
MYCN proto-oncogene, bHLH transcription factor | 0.454 | 0.808 | 0.89 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
glypican 3 | 0.466 | 0.808 | 1.00 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
nephrocystin 3 | 0.597 | 0.654 | 9.8E-16 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
growth differentiation factor 1 | 0.529 | 0.692 | 0.41 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
glypican 4 | 0.547 | 0.769 | 0.93 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
multiple EGF like domains 8 | 0.584 | 0.538 | 1.9E-05 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
matrix metallopeptidase 21 | 0.621 | 0.385 | 1.3E-09 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
RNA, 7SL, cytoplasmic 263, pseudogene | 0.496 | 0.808 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2019 | 2019 | |||||||||
|
nuclear receptor subfamily 5 group A member 1 | 0.479 | 0.731 | 0.99 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 |